Emergent BioSolutions EBS
NYSE EBS
$6.24 +0.01 (+0.16%)
As of: Oct 23, 2026 · 3:59 PM EDT

Emergent BioSolutions (EBS) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Emergent BioSolutions (EBS) reported Return on Capital Employed [ROCE] of -6.02% for Q2 2026, down 14.25 percentage points from 8.23% a year earlier and down 11.21 percentage points from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Emergent BioSolutions posted Return on Capital Employed [ROCE] of 8.19%, up 15.72 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of -11.55 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -7.53% in FY2024 (+31.88 pp), -39.40% in FY2023 (-30.13 pp), -9.27% in FY2022 (-22.68 pp) and 13.41% in FY2021 (-6.34 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since Q1 2025.
  • Year over year, Return on Capital Employed [ROCE] gained in seven of the last eight quarters, with an average year-over-year change of +27.38 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q4 2024 (a gain of 51.64 percentage points); the low point was Q3 2023 (a drop of 60.53 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 5.18% (Q1 2026), 7.96% (Q4 2025) and 9.10% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.52%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 17.92%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.28%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 16.76%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -5.97%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.86%
10 Emergent BioSolutions 321.73 Mn -429.17 Mn 137.20 Mn -6.02%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.02%
Mar 31, 2026 5.18%
Dec 31, 2025 7.96%
Sep 30, 2025 9.10%
Jun 30, 2025 8.23%
Mar 31, 2025 -7.61%
Dec 31, 2024 -8.55%
Sep 30, 2024 -11.30%
Jun 30, 2024 -43.28%
Mar 31, 2024 -45.55%
Dec 31, 2023 -60.19%
Sep 30, 2023 -53.78%
Jun 30, 2023 -28.92%
Mar 31, 2023 -17.61%
Dec 31, 2022 -9.43%
Sep 30, 2022 6.75%
Jun 30, 2022 6.96%
Mar 31, 2022 9.78%
Dec 31, 2021 13.45%
Sep 30, 2021 12.38%
API Access

Emergent BioSolutions Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EBS&period=max&api_key=YOUR_API_KEY